These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780 [TBL] [Abstract][Full Text] [Related]
3. Images in clinical medicine. Four artificial heart valves. Bijl M; van den Brink RB N Engl J Med; 2005 Aug; 353(7):712. PubMed ID: 16107624 [No Abstract] [Full Text] [Related]
4. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature. Hendrikx M; Van Dorpe J; Flameng W; Daenen W J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020 [TBL] [Abstract][Full Text] [Related]
5. Cardiac surgery for ergotamine-induced multivalvular heart disease. Lazopoulos G; Papaioannou G; Kantartzis M Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795 [TBL] [Abstract][Full Text] [Related]
10. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?]. Creutzig A Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287 [No Abstract] [Full Text] [Related]
11. Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine. Wilke A; Hesse H; Hufnagel G; Maisch B Eur Heart J; 1997 Apr; 18(4):701. PubMed ID: 9129909 [No Abstract] [Full Text] [Related]
12. [Retroperitoneal fibrosis associated with chronic use of ergotamine: report of one case]. Vega J; Goecke H; Santamarina M Rev Med Chil; 2011 Apr; 139(4):489-94. PubMed ID: 21879189 [TBL] [Abstract][Full Text] [Related]
13. Ergotamine-induced acute vascular insufficiency of the lower limb--a case report. Halloul Z; Meyer F; Lippert H; Buerger T Angiology; 2001 Mar; 52(3):217-21. PubMed ID: 11269787 [TBL] [Abstract][Full Text] [Related]
14. How can a migraine cause faecal incontinence? Honein K; Boujaoude J; Chemaly M; Yaghi C; Karam R; Sayegh R Gut; 2005 Dec; 54(12):1817, 1824. PubMed ID: 16284292 [No Abstract] [Full Text] [Related]
15. Reversal of ergotamine-induced vasospasm following methylprednisolone. Rahman A; Yildiz M; Dadas E; Donder E; Cihangiroglu M; Eken C; Bozdemir MN Clin Toxicol (Phila); 2008 Dec; 46(10):1074-6. PubMed ID: 18763151 [TBL] [Abstract][Full Text] [Related]
17. [After the numerous ergotamine preparations are on the way out. Migraine patients to change over to triptans]. MMW Fortschr Med; 2003 Oct; 145(42):63. PubMed ID: 14655450 [No Abstract] [Full Text] [Related]
18. Ventricular fibrillation secondary to ergotamine in a healthy young woman. Velez Roa S; Preumont N; Mols P; Stoupel E; Renard M Acta Cardiol; 1999 Oct; 54(5):283-6. PubMed ID: 10596308 [TBL] [Abstract][Full Text] [Related]
19. Transcranial Doppler ultrasonographic features during drug withdrawal from drug-induced headache. A transcranial Doppler follow-up study. Haase CG; Diener HC Headache; 1998 Oct; 38(9):679-83. PubMed ID: 15613180 [TBL] [Abstract][Full Text] [Related]
20. [Retroperitoneal fibrosis secondary to ergotamine use]. Martín Azcárate MD; Hernández Muro G; Isusquiza I An Med Interna; 2006 Apr; 23(4):193-4. PubMed ID: 16796416 [No Abstract] [Full Text] [Related] [Next] [New Search]